Table 1. Differential expression of the cancer/testis antigens in benign prostate, primary prostate cancer and metastatic prostate cancer.
| GEOa accession no. 1439 | Benign prostate(n=6) | Primary prostate cancer(n=7) | Metastatic prostate cancer(n=6) |
|---|---|---|---|
| SSX2 | 0.0 | 0.0 | 436.9 |
| CSAG2 | 0.0 | 0.0 | 1018.2 |
| MAGEA2 | 0.0 | 0.0 | 229.0 |
| MAGEA12 | 0.0 | 0.0 | 1139.7 |
| CEP55 | 0.0 | 56.0 | 640.2 |
| NUF2 | 14.1 | 32.3 | 1788.6 |
| PBK | 30.1 | 120.3 | 1411.5 |
| TTK | 83.8 | 216.0 | 1187.1 |
| PAGE4 | 6732.5 | 5702.8 | 0.0 |
| TBP | 608.7 | 577.6 | 882.2 |
| ACTB | 42572.0 | 41320.7 | 38735.7 |
a
GEO; The Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo).